RTW Biotech Opportunities (LON:RTW – Get Free Report)’s stock price fell 1.4% during trading on Thursday . The stock traded as low as GBX 1.38 ($0.02) and last traded at GBX 1.38 ($0.02). 84,349 shares traded hands during trading, a decline of 83% from the average session volume of 482,977 shares. The stock had previously closed at GBX 1.40 ($0.02).
RTW Biotech Opportunities Price Performance
The stock’s 50 day moving average is GBX 1.51 and its two-hundred day moving average is GBX 1.52. The firm has a market capitalization of £4.63 million, a P/E ratio of 3.83 and a beta of 0.60.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Read More
- Five stocks we like better than RTW Biotech Opportunities
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Micron Stock Under $100: Seize the AI-Driven Upside
- How to Start Investing in Real Estate
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Are Penny Stocks a Good Fit for Your Portfolio?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
